Jonathan Rubin

Jonathan Rubin

Director Técnico/Científico/I+D en SUPERNUS PHARMACEUTICALS, INC. .

Fortuna: 4 M $ al 30/06/2026

64 años
Health Technology
Consumer Services
Consumer Durables

Perfil

Jonathan Rubin is Chief Medical Officer, SVP-Research & Development at Supernus Pharmaceuticals, Inc. since 2021.
Formerly, Dr. Rubin was Chief Medical Officer at Atentiv LLC from 2018 to 2020, Director-Medical Clinical Development at Shire Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer at Alcobra Ltd. from 2013 to 2017, and Medical Director at Shire Development LLC.
Education includes undergraduate studies at Yale University, an MBA from Columbia Business School, and a doctorate from The University of Connecticut School of Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
0,13 %
31/12/2024 144.849 ( 0,13 % ) 3 M $ 30/06/2026
29/04/2026 13.341 ( 0,02 % ) 620 490 $ 30/06/2026

Cargos activos de Jonathan Rubin

EmpresasCargoInicio
SUPERNUS PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 01/01/2021

Antiguos cargos conocidos de Jonathan Rubin.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/02/2020
Director Técnico/Científico/I+D 01/09/2017
Corporate Officer/Principal 01/09/2017
Shire Development LLC
Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de Jonathan Rubin.

Formación de Jonathan Rubin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

28

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Shire Development LLC

Consumer Durables

Technology Services